HPV Vaccine Gets Less Cost-Effective As Women Age

August 22, 2008

A new government-funded study has found that the HPV vaccine Gardasil gets less and less cost-effective as women get older....Washington (ChattahBox) – A new government-funded study has found that the HPV vaccine Gardasil gets less and less cost-effective as women get older.

Researchers from the Harvard School of Public Health carried out the study by looking at just how cost-effective the HPV vaccine is.

Gardasil works by protecting against two types of HPV, which lead to 70% of cervical cancer cases.

The HPV vaccine Gardasil was made public in 2006 for girls and women aged 9 to 26.

Since its release, there have been many who have been pushing for women late into their 20s to receive the vaccine.

The problem though is that it is expensive, as Gardasil is given in three doses over the course of six months, with a price tag of $350.

Researchers concluded that as women get into their 20s, the vaccine is far less cost-effective.


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.